Accutar Biotechnology
Phase 1Accutar Biotechnology develops AI-driven drug discovery platforms and small molecule therapeutics targeting oncology and other diseases.
Founded
2015
Focus
AI / Machine Learning
About
Accutar Biotechnology develops AI-driven drug discovery platforms and small molecule therapeutics targeting oncology and other diseases.
Funding History
6Total raised: $330M
Series C$100MOrbiMedDec 15, 2021
Series C$100MIDG CapitalDec 15, 2020
Series B$50MHillhouse CapitalJan 15, 2020
Series B$50MIDG CapitalDec 15, 2018
Company Info
TypePrivate
Founded2015
LocationJersey City, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile